AU2824899A - Cause, in vitro determination and eradication of cancer - Google Patents

Cause, in vitro determination and eradication of cancer

Info

Publication number
AU2824899A
AU2824899A AU28248/99A AU2824899A AU2824899A AU 2824899 A AU2824899 A AU 2824899A AU 28248/99 A AU28248/99 A AU 28248/99A AU 2824899 A AU2824899 A AU 2824899A AU 2824899 A AU2824899 A AU 2824899A
Authority
AU
Australia
Prior art keywords
eradication
cancer
cause
vitro determination
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28248/99A
Other languages
English (en)
Inventor
Radomir Spetik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2824899A publication Critical patent/AU2824899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU28248/99A 1999-02-19 1999-03-29 Cause, in vitro determination and eradication of cancer Abandoned AU2824899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ555-99 1999-02-19
CZ1999555A CZ9900555A3 (cs) 1999-02-19 1999-02-19 Způsob mimotělní identifikace maligního a jiného onemocnění lidí a směs látek jako stimulantu krve
PCT/CZ1999/000009 WO2000049414A1 (en) 1999-02-19 1999-03-29 Cause, in vitro determination and eradication of cancer

Publications (1)

Publication Number Publication Date
AU2824899A true AU2824899A (en) 2000-09-04

Family

ID=5461898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28248/99A Abandoned AU2824899A (en) 1999-02-19 1999-03-29 Cause, in vitro determination and eradication of cancer

Country Status (5)

Country Link
EP (1) EP1163525A1 (cs)
AU (1) AU2824899A (cs)
CZ (1) CZ9900555A3 (cs)
SK (1) SK13762001A3 (cs)
WO (1) WO2000049414A1 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
PL2895163T3 (pl) 2012-09-11 2019-10-31 Norgine Bv Kompozycje zawierające PEG i askorbinian

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9105986A (pt) * 1990-02-05 1992-11-10 Univ Texas Formulacao de liberacao por tempo de vitaminas,minerais e outros suplementos beneficos
RU2018833C1 (ru) * 1990-02-28 1994-08-30 Ивановский научно-исследовательский институт материнства и детства Способ прогнозирования течения процесса адаптации у школьников при возвращении из южного санатория
CA2089607C (en) * 1992-11-05 1997-11-04 Ranjit K. Chandra Nutritional supplement for the elderly

Also Published As

Publication number Publication date
WO2000049414A1 (en) 2000-08-24
SK13762001A3 (sk) 2003-09-11
EP1163525A1 (en) 2001-12-19
CZ9900555A3 (cs) 2000-10-11

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU8026600A (en) Brachytherapy instrument and methods
AU2002219782A1 (en) Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU715620C (en) Therapeutic methods and uses
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AUPQ342599A0 (en) Conjugates and uses thereof
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU1083501A (en) Antibiotic-metal complex and methods
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU2297201A (en) Uses of antileukoprotease in carcinoma
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2136401A (en) P450rai-2 and related proteins
AU2824899A (en) Cause, in vitro determination and eradication of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU2669201A (en) Taccalonolides and their use
AU5979300A (en) Angiopoietin-6 and uses thereof
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU5632500A (en) Cancer associated antigens and uses therefor
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU6204400A (en) Novel kinases and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase